Compare CCLD & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCLD | RCEL |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | 3650 | 226 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 132.0M |
| IPO Year | N/A | N/A |
| Metric | CCLD | RCEL |
|---|---|---|
| Price | $2.62 | $4.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $1.50 | ★ $7.88 |
| AVG Volume (30 Days) | ★ 274.6K | 215.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | $21.69 |
| Revenue Next Year | $12.06 | $49.58 |
| P/E Ratio | $32.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.14 | $3.22 |
| 52 Week High | $4.01 | $10.28 |
| Indicator | CCLD | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 53.67 |
| Support Level | $2.00 | $4.11 |
| Resistance Level | $2.75 | $5.89 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 64.89 | 31.44 |
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.